Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,343 | 220 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,069 | 44 | $0 (2024) |
| Lilly USA, LLC | $579.00 | 30 | $0 (2022) |
| Novo Nordisk Inc | $570.23 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $504.29 | 16 | $0 (2021) |
| Astellas Pharma US Inc | $345.31 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $290.92 | 8 | $0 (2022) |
| Allergan Inc. | $246.06 | 5 | $0 (2019) |
| PFIZER INC. | $233.89 | 8 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $213.67 | 2 | $0 (2019) |
| Amgen Inc. | $192.99 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275.13 | 14 | Seqirus USA Inc ($45.34) |
| 2023 | $270.55 | 8 | GlaxoSmithKline, LLC. ($162.75) |
| 2022 | $419.13 | 21 | Lilly USA, LLC ($192.45) |
| 2021 | $677.08 | 46 | GlaxoSmithKline, LLC. ($173.98) |
| 2020 | $428.80 | 27 | GlaxoSmithKline, LLC. ($120.92) |
| 2019 | $1,825 | 47 | Novartis Pharmaceuticals Corporation ($333.46) |
| 2018 | $927.29 | 34 | Novo Nordisk Inc ($357.12) |
| 2017 | $519.52 | 23 | GlaxoSmithKline, LLC. ($133.18) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: WOMENS HEALTH | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Biological | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Bone Health | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $19.52 | General |
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: WOMENS HEALTH | ||||||
| 04/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $45.34 | General |
| Category: Vaccines | ||||||
| 02/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.80 | General |
| 01/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Oncology | ||||||
| 10/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Obesity | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $149.51 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Obesity | ||||||
| 07/26/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Bone Health | ||||||
| 07/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Bone Health | ||||||
| 11/30/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Diabetes | ||||||
| 11/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 539 | 1,033 | $89,313 | $37,279 |
| 2022 | 11 | 673 | 1,323 | $115,557 | $50,231 |
| 2021 | 13 | 534 | 1,016 | $95,750 | $45,211 |
| 2020 | 17 | 719 | 1,638 | $111,472 | $39,711 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 410 | $48,790 | $21,908 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 149 | $26,224 | $10,780 | 41.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 112 | 197 | $2,955 | $1,655 | 56.0% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 11 | 12 | $1,140 | $1,117 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 111 | $4,329 | $841.11 | 19.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 15 | $825.00 | $519.30 | 62.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 19 | $475.00 | $180.88 | 38.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 25 | 32 | $800.00 | $135.33 | 16.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 13 | 26 | $780.00 | $100.10 | 12.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 35 | 42 | $2,520 | $26.07 | 1.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 20 | $475.03 | $15.28 | 3.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 191 | 508 | $60,452 | $29,746 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 221 | $38,896 | $16,779 | 43.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 80 | 156 | $6,084 | $1,458 | 24.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 21 | 22 | $1,210 | $766.26 | 63.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 115 | 184 | $2,384 | $543.93 | 22.8% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 14 | 14 | $1,316 | $391.58 | 29.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 39 | 44 | $710.00 | $206.51 | 29.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 16 | $960.00 | $137.41 | 14.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 49 | 109 | $2,800 | $95.17 | 3.4% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 13 | 17 | $510.00 | $65.93 | 12.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 32 | $235.00 | $40.65 | 17.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 159 | 447 | $53,193 | $26,930 | 50.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 181 | $31,856 | $14,246 | 44.7% |
| 90653 | Vaccine for influenza for injection into muscle, inactivated | Office | 2021 | 18 | 18 | $1,170 | $1,072 | 91.6% |
About Dr. Ardy Wright, M.D
Dr. Ardy Wright, M.D is a Family Medicine healthcare provider based in Cynthiana, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558455030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ardy Wright, M.D has received a total of $5,343 in payments from pharmaceutical and medical device companies, with $275.13 received in 2024. These payments were reported across 220 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,343).
As a Medicare-enrolled provider, Wright has provided services to 2,465 Medicare beneficiaries, totaling 5,010 services with total Medicare billing of $172,431. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cynthiana, KY
- Active Since 10/02/2006
- Last Updated 02/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558455030
Products in Payments
- TRELEGY ELLIPTA (Drug) $616.65
- ENTRESTO (Drug) $504.29
- TRULICITY (Drug) $285.93
- JARDIANCE (Drug) $228.19
- AJOVY (Drug) $213.67
- VRAYLAR (Drug) $209.76
- ANORO (Drug) $188.53
- Ozempic (Drug) $170.92
- AREXVY (Drug) $149.51
- EVENITY (Biological) $143.37
- MOUNJARO (Drug) $142.36
- VESICARE (Drug) $125.62
- Vascepa (Drug) $122.97
- SOLIQUA 100/33 (Drug) $122.85
- Saxenda (Drug) $122.22
- LONHALA MAGNAIR (Drug) $118.54
- ANORO ELLIPTA (Drug) $113.95
- TRUMENBA (Biological) $112.34
- MYRBETRIQ (Drug) $108.45
- Tresiba (Drug) $106.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cynthiana
Brian Mulberry, Md, MD
Family Medicine — Payments: $17,475
Richard Norfleet, Md, MD
Family Medicine — Payments: $12,308
Dr. Stephen Moses, M.d, M.D
Family Medicine — Payments: $11,158
John Cooper, Md, MD
Family Medicine — Payments: $7,084
Richard Risher, M.d, M.D
Family Medicine — Payments: $2,161
Maurice Mcglone, Do, DO
Family Medicine